Tasso - About the company
Tasso is a series B company based in Seattle (United States), founded in 2014 by Ben Casavant. It operates as a Developer of blood collection device for diagnostic applications. Tasso has raised $131M in funding from investors like RA Capital Management, Cedars-Sinai Accelerator and Vertical Venture Partners. The company has 22 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like YourBio Health, Babson Diagnostics and Avia Vascular.
Company Details
Developer of blood collection device for diagnostic applications. The products developed by the company include TASSO+, TASSO-M20, and TASSO-SST collects whole liquid blood samples that are ready to be used for a variety of downstream applications.
- Website
- www.tassoinc.com/
- Email ID
- *****@tassoinc.com
- Phone Number
- +1 **********
- Registered Address
- Rukki tn 13
Key Metrics
Founded Year
2014
Location
Seattle, United States
Stage
Series B
Total Funding
$131M in 8 rounds
Latest Funding Round
Investors
Ranked
1st among 22 active competitors
Employee Count
100 as on Jun 30, 2026
Similar Companies
Legal entities associated with Tasso
Tasso is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Tasso OÜ CIN: 14586400 , Estonia, Active | Oct 14, 2018 | €0 - €1M (As on Dec 31, 2023) | 1 (As on Sep 30, 2024) |
Sign up to download Tasso's company profile
Tasso's funding and investors
Tasso has raised a total funding of $131M over 8 rounds. Its latest funding round was a Series B round on Dec 16, 2021 for $*****. 10 investors participated in its latest round. Tasso has 19 institutional investors.
Here is the list of recent funding rounds of Tasso:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 16, 2021 | 8447245 | Series B | 2587337 | 1701469 | 4292132 | 8533546 |
Jul 21, 2020 | 4584110 | Series A | 5441331 | 6737856 | 3518448 | |
Mar 05, 2019 | 5234156 | Series A | 5676772 | 1220927 |
View details of Tasso's funding rounds and investors
Tasso's founders and board of directors
Founder? Claim ProfileThe founders of Tasso is Ben Casavant.
Here are the details of Tasso's key team members:
- Ben Casavant: Co-Founder of Tasso. Contact Info: 1 email address
View details of Tasso's Founder profiles and Board Members
Tasso's employee count trend
Tasso has 100 employees as of Jun 26. Here is Tasso's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Tasso's Competitors and alternates
Top competitors of Tasso include YourBio Health, Babson Diagnostics and Avia Vascular. Here is the list of Top 10 competitors of Tasso, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Tasso 2014, Seattle (United States), Series B | Developer of blood collection device for diagnostic applications | $131M | 63/100 | |
2nd | YourBio Health 2007, Medford (United States), Acquired | Manufacturer of push-button blood collection device | $102M | 52/100 | |
3rd | Babson Diagnostics 2017, Austin (United States), Series B | Provider of blood testing service using microsamples collected from a finger. | $44.7M | 44/100 | |
4th | Avia Vascular 2020, Salt Lake City (United States), Funding Raised | Developer of needle-free blood collection devices | - | 42/100 | |
5th | Velano Vascular 2012, San Francisco (United States), Acqui-Hired | Provider of a needle-free blood collection device | $51.1M | 38/100 | |
6th | RegenLab 2003, Brooklyn (United States), Funding Raised | Provider of medical devices to develop cellular therapies | - | - | 37/100 |
7th | ![]() Lobio 2020, Rockville (United States), Funding Raised | Developer of at-home plasma collection device for clinical laboratory testing | - | 37/100 | |
8th | DBS System 2010, Gland (Switzerland), Series A | Manufacturer of device for plasma and serum extraction | $2.52M | 33/100 | |
9th | IOTA Diagnostic 2020, Gandhinagar (India), Seed | Provider of blood micro-sampling device for diagnostics | - | 31/100 | |
10th | Lo Biosciences 2020, Bethesda (United States), Seed | Developer of blood collection device | $20K | 30/100 |
Looking for more details on Tasso's competitors? Click here to see the top ones
Tasso's Investments and acquisitions
Tasso has made no investments or acquisitions yet.
Reports related to Tasso
Here is the latest report on Tasso's geography:
News related to Tasso
Media has covered Tasso for a total of 4 events in the last 1 year, 3 of them have been about partnerships and 1 about company updates.
•
Partnership between Tasso and the Parkinson’s Foundation Reveals New Genetic DataBusiness Wire•Mar 31, 2026•Tasso
•
•
•
Tasso & SheMed Offer At-Home Blood Testing for Personalized GLP-1 Treatments to UK WomenBusiness Wire•Aug 27, 2025•Tasso, SheMed
•
•
Tasso Announces Next Generation Technology for Patient-Centric Dried Blood Spot Sample CollectionBusiness Wire•Feb 11, 2025•Tasso
•
•
InnoVero and Tasso Extend Partnership Providing Athlete-Centric Solutions for Anti-Doping TestingBusiness Wire•Jul 09, 2024•InnoVero, Tasso
•
•
Tasso Receives CE Mark Certification for Tasso+™, Latest Generation Whole Blood Collection Lancet DeviceMedTech Innovator•Sep 19, 2023•Tasso
Are you a Founder ?
FAQs about Tasso
Explore our recently published companies
- AI TrackScore - 2026 founded, Unfunded company
- agriQ - United Kingdom based, 2026 founded, Unfunded company
- Momentum AI - Las Condes based, 2026 founded, Unfunded company
- BME Consultancy - Eindhoven based, 2026 founded, Unfunded company
- Xienenggongchuang - Chengdu based, 2017 founded, Unfunded company
- Sishengxinxi - Xuhui based, 2014 founded, Unfunded company
